A new centre “4 Humanity” was launched in Egypt

As part of ongoing efforts to expand the reach of the Phase III clinical trials of the inactivated COVID-19 vaccine, a new centre 4 Humanity was launched in Egypt, making it the fourth Arab country to participate in these trials following the UAE, Bahrain and Jordan.

The extension follows the successful launch of the trials in the UAE on 16 July by G42 Healthcare and Sinopharm CNBG, with 31,000+ volunteers from 125 nationalities in the UAE vaccinated, representing double the required number of volunteers.